Daniel Chober

ORCID

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Venues

Journal of clinical medicine

Biomedicines

HIV medicine

Journal of inflammation research

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Chober, Bogusz Jan Aksak-Wąs, Jolanta Niścigorska-Olsen, Małgorzata Niekrasz, Miłosz Parczewski
Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia-A Retrospective Study. Biomedicines 10 (7) (2022)
Bogusz Jan Aksak-Wąs, Justyna Dominika Kowalska, Piotr Ząbek, Karol Serwin, Milena Rafalska-Kosior, Joanna Gołąb, Daniel Chober, Karolina Skonieczna-Żydecka, Małgorzata Hackiewicz, Miłosz Parczewski
Immune restoration affects 10-year survival in people living with HIV/AIDS. HIV medicine (2022)
Daniel Chober, Bogusz Jan Aksak-Wąs, Katarzyna Bobrek-Lesiakowska, Anna Budny-Finster, Ewa Hołda, Joanna Mieżyńska-Kurtycz, Grzegorz Jamro, Miłosz Parczewski
Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study. Journal of clinical medicine 11 (9) (2022)
Bogusz Jan Aksak-Wąs, Anna Urbańska, Kaja Scheibe, Karol Serwin, Magdalena Leszczyszyn-Pynka, Milena Rafalska-Kosior, Joanna Gołąb, Daniel Chober, Miłosz Parczewski
Factors Influencing Immune Restoration in People Living with HIV/AIDS. Journal of clinical medicine 11 (7) (2022)
Bogusz Jan Aksak-Wąs, Daniel Chober, Karol Serwin, Kaja Scheibe, Jolanta Niścigorska-Olsen, Anna Niedźwiedź, Monika Dobrowolska, Katarzyna Żybul, Marta Kubacka, Agnieszka Zimoń, Ewa Hołda, Joanna Mieżyńska-Kurtycz, Marta Gryczman, Grzegorz Jamro, Paweł Szakoła, Miłosz Parczewski
Remdesivir Reduces Mortality in Hemato-Oncology Patients with COVID-19. Journal of inflammation research 15 (2022)

Daniel Chober.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Chober